Mucommune, a Morrisville-based biotechnology company with roots at the University of North Carolina at Chapel Hill, has been ...

New legislation proposed by a bipartisan and bicameral group of Congressional legislators and supported by the North Carolina ...

Precise Bio Inc., a Greensboro-based clinical-stage regenerative medicine company, has announced the world’s first transplant ...

A catalyst for technology-based economic development in life sciences . In 1984, three of North Carolina’s largest ...

Novartis has operated in North Carolina for more than two decades, delivering gene therapies and other lifesaving treatments ...

If you want to know how therapeutic innovation in the Triangle stacks up against other life sciences hubs, just ask an investor who knows the national and global landscape. Nima Ronaghi, principal at ...

Biotechnology education has a long and significant history in North Carolina’s Piedmont Triad region of Alamance County. Alamance County is lauded as the top small metropolitan statistical area in the ...

Tract Bio, a Boston-based biotechnology company developing novel therapies for cancer and inflammatory diseases, has opened a new research laboratory in Charlotte with plans to grow. The 4,000 ...

Durham-based Priovant Therapeutics, with Roivant Sciences, has shared encouraging results from its Phase 3 VALOR study evaluating brepocitinib, a potential new treatment for the autoimmune disease ...

URO-1, a Greensboro medical device company in prostate and soft tissue cancer diagnostics, said it was recently approved by Novant Health as a designated vendor for URO-1’s SUREcore and coreCARE ...

Durham Technical Community College and Novo Nordisk officials broke ground this week on a new $41.2 million life sciences education center that will prepare students for careers in North Carolina's ...